Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.00	-44.67	-51.95
Graham Fair Price	2.34	97977.04	95736.26
PEG	-62.58	1.03	-2.76
Price/Book	36.20	-1.78	-2.79
Price/Cash Flow	46.04	-16.26	-30.14
Prices/Earnings	26.63	-4.72	-6.44
Price/Sales	0.55	38.54	38.33
Price/FCF	46.04	-16.26	-30.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-24.35	-0.50	-0.40
Operating Margin	-32.76	-1.39	-1.05
ROA	14.02	-0.10	-0.12
ROE	0.11	0.09	-13.05
ROIC	0.17	0.13	-22.13
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.06	-51.67
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	0.07	-67.09
EPS QOQ	-0.02	0.05	96.06
FCF QOQ	0.54	-0.30	-44.47
Revenue QOQ	0.26	-0.30	15.48
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	176.78	220.88	24.94
Days Sales Outstanding (DSO)	94.56	153.07	61.88
Inventory Turnover	0.51	0.41	-19.96
Debt/Capitalization	-1.19	-1.04	12.68
Quick Ratio	0.11	0.10	-11.07
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-61327.13	-67307.00	-9.75
Cash	1715.97	1267.58	-26.13
Capex	-2174.99	-2056.46	5.45
Free Cash Flow	-5675.10	-7364.34	-29.77
Revenue	4462.02	3107.31	-30.36
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.35	0.29	-16.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-8.11	-9.66	-19.19
Naive Interpretation	Member

06 - Financial Health · Bad

Rating